 CAMBRIDGE, Mass.-- BUSINESS WIRE --Enveric Biosciences NASDAQ: ENVB Enveric or the Company, a biotechnology company dedicated to the development of novel small-molecule therapeutics for the treatment of anxiety, depression and addiction disorders, announced today that the company will present at the 6th Annual Neuroscience Forum and the Biotech ShowcaseTM. Both events will be held live and are scheduled to coincide with the 41st Annual J.P. Morgan Health Care Conference in San Francisco, January 9-12, 2023. 